Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 704

1.

Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.

Gandola L, Massimino M, Cefalo G, Solero C, Spreafico F, Pecori E, Riva D, Collini P, Pignoli E, Giangaspero F, Luksch R, Berretta S, Poggi G, Biassoni V, Ferrari A, Pollo B, Favre C, Sardi I, Terenziani M, Fossati-Bellani F.

J Clin Oncol. 2009 Feb 1;27(4):566-71. doi: 10.1200/JCO.2008.18.4176. Epub 2008 Dec 15.

PMID:
19075266
2.

No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.

Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1358-63. doi: 10.1016/j.ijrobp.2008.06.1930. Epub 2008 Nov 18.

PMID:
19019566
3.

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

Kortmann RD, Kühl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sörensen N, Warmuth-Metz M, Bamberg M.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):269-79.

PMID:
10661332
4.

Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.

Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS.

Eur J Cancer. 2005 Mar;41(5):727-34. Epub 2005 Jan 18.

PMID:
15763649
5.
6.

Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.

Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1031-7. Epub 2005 Dec 15.

PMID:
16343801
7.

Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.

Hartsell WF, Gajjar A, Heideman RL, Langston JA, Sanford RA, Walter A, Jones D, Chen G, Kun LE.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):15-24.

PMID:
9300735
8.
9.

Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.

Taylor RE, Bailey CC, Robinson KJ, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Saran F, Walker DA, Pizer BL, Lashford LS; United Kingdom Children's Cancer Study Group Brain Tumour Committee; International Society of Paediatric Oncology.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1184-93.

PMID:
15001263
10.

Survival of adults treated for medulloblastoma using paediatric protocols.

Spreafico F, Massimino M, Gandola L, Cefalo G, Mazza E, Landonio G, Pignoli E, Poggi G, Terenziani M, Pedrazzoli P, Siena S, Fossati-Bellani F.

Eur J Cancer. 2005 Jun;41(9):1304-10.

PMID:
15869875
11.

Medulloblastoma: time-dose relationship based on a 30-year review.

del Charco JO, Bolek TW, McCollough WM, Maria BL, Kedar A, Braylan RC, Mickle JP, Buatti JM, Mendenhall NP, Marcus RB Jr.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):147-54.

PMID:
9747832
12.

Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma--a safety/feasibility study.

Taylor RE, Howman AJ, Wheatley K, Brogden EE, Large B, Gibson MJ, Robson K, Mitra D, Saran F, Michalski A, Pizer BL.

Radiother Oncol. 2014 Apr;111(1):41-6. doi: 10.1016/j.radonc.2014.01.022. Epub 2014 Mar 11.

PMID:
24630538
13.

[High-dose chemotherapy in relapse of medulloblastoma in young children].

Dupuis-Girod S, Hartmann O, Benhamou E, Doz F, Mechinaud F, Bouffet E, Coze C, Kalifa C.

Bull Cancer. 1997 Mar;84(3):264-72. Review. French.

14.

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R.

J Clin Oncol. 2006 Sep 1;24(25):4202-8.

PMID:
16943538
15.

Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.

Dhall G, Grodman H, Ji L, Sands S, Gardner S, Dunkel IJ, McCowage GB, Diez B, Allen JC, Gopalan A, Cornelius AS, Termuhlen A, Abromowitch M, Sposto R, Finlay JL.

Pediatr Blood Cancer. 2008 Jun;50(6):1169-75. doi: 10.1002/pbc.21525.

PMID:
18293379
16.

[Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].

Grabenbauer GG, Löhnert C, Erhardt J, Buchfelder M, Neubauer U, Beck JD, Reitz S, Seyer H, Thierauf P, Fietkau R, et al.

Strahlenther Onkol. 1993 Apr;169(4):213-21. German.

PMID:
8488458
17.

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL.

J Clin Oncol. 2004 Dec 15;22(24):4881-7. Erratum in: J Clin Oncol. 2005 Apr 20;23(12):2877.

PMID:
15611503
19.

Medulloblastoma in adults: treatment results and prognostic factors.

Abacioglu U, Uzel O, Sengoz M, Turkan S, Ober A.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):855-60.

PMID:
12377339
20.

Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.

Sirachainan N, Nuchprayoon I, Thanarattanakorn P, Pakakasama S, Lusawat A, Visudibhan A, Dhanachai M, Larbcharoensub N, Amornfa J, Shotelersuk K, Katanyuwong K, Tangkaratt S, Hongeng S.

J Clin Neurosci. 2011 Apr;18(4):515-9. doi: 10.1016/j.jocn.2010.08.012.

PMID:
21310618

Supplemental Content

Support Center